Oralta Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $250K
Latest Deal Amount
  • Investors
  • 2

Oralta General Information

Description

Provider of probiotic supplement intended to fight bad breath. The company's supplement is blend of five highly effective strains which has been created to restore a healthy equilibrium of beneficial bacteria and thereby eliminate odor causing bad bacteria in a natural and sustainable way, enabling users to keep regain their confidence with fresh breath.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Internet Retail
Primary Office
  • San Francisco, CA
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oralta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 25-Jul-2018 $250K 00000 00.000 Completed Generating Revenue
To view Oralta’s complete valuation and funding history, request access »

Oralta Executive Team (4)

Name Title Board Seat Contact Info
Kishore Nannapaneni Ph.D Co-Founder & Chief Executive Officer
Patrick Schwientek Ph.D Co-Founder & Chief Technology Officer
David Drake Ph.D Co-Founder & CSO
Jeffrey Banas Ph.D Co-Founder & Vice President, Microbiology
To view Oralta’s complete executive team members history, request access »

Oralta Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
IndieBio Accelerator/Incubator Minority 000 0000 000000 0
SOSV Accelerator/Incubator Minority 000 0000 000000 0
To view Oralta’s complete investors history, request access »